Encore Healthcare is committed to providing high quality products at an affordable price, says Viren Merchant, founder and ...

As global markets navigate a turbulent landscape marked by lower stock performances amid busy earnings reports and mixed economic signals, small-cap stocks have demonstrated resilience compared to ...

Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will ...

RBC Capital lowered the firm’s price target on Pharming (PHAR) to EUR 1.60 from EUR 1.65 and keeps an Outperform rating on the shares.

Analysts at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for shares of Pharming Group in a research note ...

Oppenheimer analyst Jeff Jones lowered the firm’s price target on Pharming (PHAR) to $30 from $31 and keeps an Outperform rating on the shares following quarterly results and business update.

Good day, and thank you for standing by. Welcome to the Pharming Group NV 3Q 2024 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After the speakers ...

Eramet announces today the buy-back of all Tsingshan Group's ("Tsingshan”) minority interest (49.9%) in Eramine Sudamerica ("Eramine”) for a net cash impact of $699 million. The transaction was ...

Chief Executive Officer, Sijmen de Vries, commented: “Pharming has delivered an excellent third quarter, increasing quarterly revenues by 12% to a record-high US$74.8 million and also achieving ...